Deoxyribonucleic acid (DNA) phosphate backbone (DNA)

The Deoxyribonucleic acid (DNA) phosphate backbone is the structural framework of the genetic material in all living organisms, composed of alternating deoxyribose sugar units and phosphate groups linked by phosphodiester bonds (National Human Genome Research Institute, 2023). In proliferating cells, this backbone is a dynamic site of activity, as the double helix must be unwound and replicated to facilitate cell division. This structural component serves as a critical therapeutic target for several classes of cytotoxic drugs, most notably alkylating agents and platinum-based compounds (StatPearls, 2023). These agents work by forming covalent adducts or cross-links with the DNA, which distorts the backbone's geometry and prevents the separation of strands necessary for replication and transcription (NCBI, 2022). The resulting structural damage activates cellular stress responses and, if irreparable, leads to programmed cell death or apoptosis (American Cancer Society, 2024). While highly effective against rapidly dividing cancer cells, drugs targeting the DNA backbone also affect healthy proliferating tissues, leading to significant clinical toxicities such as myelosuppression and gastrointestinal distress.

Other names

DNA backbonePhosphodiester backboneSugar-phosphate backboneDeoxyribonucleic acid phosphate chain

Drugs targeting the DNA phosphate backbone typically act by forming covalent adducts or cross-links between DNA strands (StatPearls, 2023). This process, known as alkylation or platination, disrupts the structural integrity of the double helix, preventing the DNA from being unzipped for replication or transcription (NCBI, 2022). The resulting DNA damage, if not repaired, activates cell cycle checkpoints and eventually leads to apoptosis, particularly in rapidly dividing cells (American Cancer Society, 2024).